Printivo
PrivateLast Round
Accelerator
Feb 9, 2017
Est. Valuation
$1.3M
Total Funding Raised
$212,500
Company Overview
Printivo operates in Healthcare & Life Sciences and is based in Sofia. Its latest recorded funding round was an Accelerator round in February 2017.
Printivo is a biotechnology company that develops 3D-bioprinted human bone tissue for in-vitro efficacy and toxicity assays in pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Printivo Comparables
Compare Printivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InSphero | 76% | |
| Brinter | 76% | |
| Ncardia | 61% |
For institutional investors. Book with your work email.
Printivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 9, 2017 | ||||
| Seed | Oct 15, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Printivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ventures Platform | Seed |
| 500 Global | Seed, Accelerator |
| EchoVC Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Monthly visitors increased 37% MoM.
- Jun 1, 2025
Monthly visitors increased 86% MoM.
For institutional investors. Book with your work email.
Printivo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Printivo's valuation, stock price, and market status.
Is Printivo a public or private company?
Printivo is a private company.
What is the current stock price of Printivo?
Printivo is a private company, so its shares have no public market price. Caplight tracks Printivo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Printivo worth (valuation)?
Printivo's valuation is estimated at $1.3M based on funding round data.
Can I buy Printivo stock?
Printivo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Printivo's last funding round?
Printivo's most recent funding round was Accelerator on February 9, 2017.
Who are the main investors in Printivo?
Key investors in Printivo include 500 Global, EchoVC Partners.
Will Printivo IPO soon?
No public IPO plans have been announced for Printivo.
How can I track Printivo secondary market activity?
Caplight tracks bids, offers, and trades in Printivo's shares on secondary markets.